From mass media entertainment, consumer products and medical manufacturers, there is a wide variety of stocks for investors to watch this month. There have been several fundamental factors that have affected and continue to affect the stock market. Most notably is the coronavirus pandemic and national vaccine programmed, which for some, has meant an increase in revenue and share value. If you are considering stock trading this month, and potentially diversifying your portfolio, here’s a round-up of the investable stocks for August.
1. Johnson & Johnson (JNJ)
As an American multinational company that manufactures medical devices, pharmaceutical and consumer products, Johnson & Johnson (JNJ) is one of the world’s most valuable companies, and is not set to devalue anytime soon.
The healthcare giant has a reputation amongst investors for its continuous growth in revenue, so is definitely one to watch this month. It’s particularly popular due to its consistent returns from dividends. At the time of writing, the JNJ stock dividend yield is around 2.46%, which is much higher than the average stock yield, from the likes of the S&P 500, of 1.35%.
It’s predicted that JNJ stocks are a likely stable investment, as there is an ongoing demand for the goods that the company produces, which in turn supports the growth of the business, the increasing value of its stock and the good returns from its dividend pay-outs. In fact, these reliant gains from the JNJ dividends, has earnt its place on the exclusive S&P 500 index list of Dividends Aristocrats. This means the company has consistently increased dividend payments on an annual basis over a certain period of time.
2. Moderna Inc. (MRNA)
Another stock from the medical sector, Morderna Inc. (MRNA) is a biotechnology company based in Massachusetts, that focuses on the discovery and development of drugs, based on the polymeric molecule, RNA. The field that they work in means that they have been a pinnacle asset in the development and production of the coronavirus vaccines.
Due to its global effect, the COVID-19 vaccines have been and continue to be in high demand, of which Moderna is currently meeting and supplying. In the first quarter of the year, the company recorded $1.7 billion worth of sales of the vaccination jab. They have also announced contracts to supply Taiwan, Japan and Argentina with further doses through to 2022. With this in mind, it’s expected that the revenue of Morderna, and its subsequent stock value, can only increase.
The sentiment of the market around this stock in particular is positive, and investors have already starting reacting accordingly, at the time of writing. Looking forward for long-term investors, Morderna also have plans to develop non-coronavirus projects, that may well sustain the company’s success and profitability.
3. The Walt Disney Co. (DIS)
The juggernaut in entertainment has certainly reached new heights recently, with the introduction of its streaming service Disney+, which has served as a beacon throughout the pandemic and maintained the company’s huge income. In fact, the company managed to drawn in 103.6 million subscribers, merely 18 months after its launch.
However, it’s the other aspects of the franchise that have piqued investors’ interests this month, as the famous Disney parks are set to reopen, at the time of writing, with some offering extended evening hours. This means that following elements of the widespread business are about to provide additional income again:
- Walt Disney World Resort
- Shanghai Disney Resort
- Disneyland Resort
- Disneyland Paris
- Hong Kong Disneyland Resort
Final Words
Although international tourists are unlikely to visit due to remaining travel restrictions, the lack of holidays abroad for the domestic public means they are likely to visit their local Disney Park during the summer break. This boost in the revenue, adding to the multiple channels of income for Disney, may well act as a catalyst for the DIS stock value, and means that investors will be closely monitoring the market, as well as awaiting the results of the company’s report earnings.
Follow Techdee for more!
